Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Registration Number : 225MF10184
Registrant's Address : 19, Academy-ro 51beon-gil, Yeonsu-gu, Incheon, 22014, Korea
Initial Date of Registration : 2013-09-25
Latest Date of Registration :
NDC Package Code : 32228-001
Start Marketing Date : 2016-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
Global Sales Information
Market Place
ABOUT THIS PAGE